ACRVVSBTAI• 3 Months (Normalized)
ACRV vs BTAI (Acrivon Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ACRV Performance $1.7
+8.28%
Acrivon Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0.07
-94.43%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ACRV LEADS
+102.71%
ACRV outperforming by 102.71%
ACRVBTAI
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ACRV BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ACRV Price | ACRV Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.70 | +8.28% | $0.07 | -94.43% | +102.71% |
| Sep 15, 2026 | $1.83 | +16.56% | $0.04 | -96.28% | +112.84% |
| Sep 14, 2026 | $1.96 | +24.84% | $0.05 | -96.24% | +121.08% |
| Sep 11, 2026 | $2.00 | +27.39% | $0.05 | -95.75% | +123.14% |
| Sep 10, 2026 | $2.04 | +29.94% | $0.05 | -95.83% | +125.77% |
| Sep 09, 2026 | $1.99 | +26.75% | $0.05 | -96.08% | +122.83% |
| Sep 08, 2026 | $2.10 | +33.76% | $0.04 | -96.42% | +130.18% |
| Sep 04, 2026 | $2.13 | +35.67% | $0.07 | -93.84% | +129.51% |
| Sep 03, 2026 | $2.06 | +31.21% | $0.12 | -90.17% | +121.38% |
| Sep 02, 2026 | $2.15 | +36.94% | $0.11 | -91.08% | +128.02% |
| Sep 01, 2026 | $2.07 | +31.85% | $0.14 | -88.58% | +120.43% |
| Aug 31, 2026 | $2.09 | +33.12% | $0.16 | -86.42% | +119.54% |
| Aug 28, 2026 | $2.06 | +31.21% | $0.18 | -84.92% | +116.13% |
| Aug 27, 2026 | $2.15 | +36.94% | $0.72 | -40.08% | +77.02% |
| Aug 26, 2026 | $2.08 | +32.48% | $0.78 | -35.00% | +67.48% |
Page 1 of 5